Paper · 41596293
Osteoporosis After Menopause and After Drug Therapy: The Molecular Mechanism of Bone Loss and Its Treatment.
Lee KI and 2 others. Int J Mol Sci, 2026. Cited by 16 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Osteoporosis After Menopause and After Drug Therapy: The Molecular Mechanism of Bone Loss and Its Treatment. Papers, record 41596293. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41596293
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Osteoporosis After Menopause and After Drug Therapy: The Molecular Mechanism of Bone Loss and Its Treatment.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bone Density Conservation Agents | Major topic |
| Osteoporosis, Postmenopausal | Major topic |
| Osteoporosis | Major topic |
| Humans | |
| Female | |
| Denosumab | |
| Animals | |
| Bone Remodeling | |
| Diphosphonates | |
| RANK Ligand |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| TCRD-TPE-114-12 | Taipei Tzu Chi Hospital | PubMed |
Source PubMed
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References169
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35,478,046 | The clinician's guide to prevention and treatment of osteoporosis. | Osteoporos Int | 2022 | https://conductscience.org/library/papers/35478046 | PubMed |
| 2 | 21,450,337 | Osteoporosis: now and the future. | Lancet | 2011 | https://conductscience.org/library/papers/21450337 | PubMed |
| 3 | 29,955,628 | Bisphosphonate-related osteonecrosis of the jaw: a mechanobiology perspective. | Bone Rep | 2018 | https://conductscience.org/library/papers/29955628 | PubMed |
| 4 | 16,936,272 | B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease. | Am J Pathol | 2006 | https://conductscience.org/library/papers/16936272 | PubMed |
| 5 | 19,209,265 | The use of calcium and vitamin D in the management of osteoporosis. | Ther Clin Risk Manag | 2008 | https://conductscience.org/library/papers/19209265 | PubMed |
| 6 | 38,655,459 | Identification of an novel genetic variant associated with osteoporosis: insights from the Taiwan Biobank Study. | JBMR Plus | 2024 | https://conductscience.org/library/papers/38655459 | PubMed |
| 7 | 32,757,960 | Associations between polymorphisms in VDR gene and the risk of osteoporosis: a meta-analysis. | Arch Physiol Biochem | 2022 | https://conductscience.org/library/papers/32757960 | PubMed |
| 8 | 22,595,550 | Estrogen and the skeleton. | Trends Endocrinol Metab | 2012 | https://conductscience.org/library/papers/22595550 | PubMed |
| 9 | 27,053,737 | Physiological Bone Remodeling: Systemic Regulation and Growth Factor Involvement. | Physiology (Bethesda) | 2016 | https://conductscience.org/library/papers/27053737 | PubMed |
| 10 | 35,933,897 | Shilajit extract reduces oxidative stress, inflammation, and bone loss to dose-dependently preserve bone mineral density in postmenopausal women with osteopenia: A randomized, double-blind, placebo-controlled trial. | Phytomedicine | 2022 | https://conductscience.org/library/papers/35933897 | PubMed |
1 to 10 of 169
See all 169 referencesCited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,942,894 | Whey Protein-Polysaccharide Nanocomplexes: Structure-Function Characterization and Bone-Related Outcomes in Ovariectomized Rats. | Nutrients | 2026 | https://conductscience.org/library/papers/42942894 | PubMed |
| 42,793,202 | Nuciferine Ameliorates Ovariectomy-Induced Bone Loss via TFEB-Mediated Autophagy-Lysosomal Pathway. | Biomolecules | 2026 | https://conductscience.org/library/papers/42793202 | PubMed |
| 42,761,519 | Targeting subchondral osteoporosis in osteoarthritis: biomechanical crosstalk and the therapeutic rationale for inflammatory microenvironment remodeling. | Front Immunol | 2026 | https://conductscience.org/library/papers/42761519 | PubMed |
| 42,739,052 | Bioactive Phytochemicals from Artocarpus integer Leaves Improve Bone-Related Outcomes in Ovariectomized Rats: An Integrated LC-HRMS, Network Pharmacology, and Experimental Study. | Nutrients | 2026 | https://conductscience.org/library/papers/42739052 | PubMed |
| 42,713,413 | Comparison of Naringenin and Alendronate in the Attenuation of Ovariectomy-Induced Osteoporosis by Modulating Autophagy, Apoptosis, and Oxidative Stress in Rats. | Iran J Pharm Res | 2026 | https://conductscience.org/library/papers/42713413 | PubMed |
| 42,706,713 | Prevalence and Associated Risk Factors of Osteoporosis in Community-Dwelling Older Adults in China: A Cross-Sectional Study of 2533 Participants. | Med Sci Monit | 2026 | https://conductscience.org/library/papers/42706713 | PubMed |
| 42,639,398 | The multisystem impact of perimenopausal hormonal fluctuations on chronic disease risk. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42639398 | PubMed |
| 42,597,306 | Circadian regulation of osteoclast lysosomal-resorption machinery: implications for osteoporosis therapy. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42597306 | PubMed |
| 42,382,177 | The recent progression of extracellular vesicles application in osteoporosis. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42382177 | PubMed |
| 42,351,672 | Humic Acid Therapy Mitigates Estrogen Deficiency-Induced Alveolar Bone Loss and Modulates the RANKL/OPG Balance. | Biomedicines | 2026 | https://conductscience.org/library/papers/42351672 | PubMed |
1 to 10 of 17
See all 17 cited byGenes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CTNNB1 | 1,499 | PubTator's text mining | https://conductscience.org/library/genes/1499 | NCBI Gene |
| SOST | 50,964 | PubTator's text mining | https://conductscience.org/library/genes/50964 | NCBI Gene |
| TNFSF11 | 8,600 | PubTator's text mining | https://conductscience.org/library/genes/8600 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41596293
GET https://conductscience.org/api/papers/v1/41596293/references?page=2